Search Results

Rotigotine/selegiline: Impulse control and obsessive compulsive disorders: 3 case reports

Source: Reactions, Volume 1, Number 1277, 2009-11-07 , pp. 36-37(2)

Publisher: Adis International

Structure, Function, Regulation and Polymorphism of Human Cytochrome P450 2A6

Authors: Di, Yuan M.; Chow, Vivian D.e.h-W.e.i.; Yang, Li-Ping; Zhou, Shu-Feng

Source: Current Drug Metabolism, Volume 10, Number 7, September 2009 , pp. 754-780(27)

Publisher: Bentham Science Publishers

Selegiline transdermal system: a novel treatment option for major depressive disorder

Authors: Nandagopal, Jayasree J; DelBello, Melissa P

Source: Expert Opinion on Pharmacotherapy, Volume 10, Number 10, July 2009 , pp. 1665-1673(9)

Publisher: Informa Healthcare

Selegiline: Hallucinations: case report

Source: Reactions, Volume 1, Number 1258, 2009-06-27 , pp. 28-28(1)

Publisher: Adis International

The increasing role of monoamine oxidase type B inhibitors in Parkinson's disease therapy

Authors: Elmer, Lawrence W; Bertoni, John M

Source: Expert Opinion on Pharmacotherapy, Volume 9, Number 16, November 2008 , pp. 2759-2772(14)

Publisher: Informa Healthcare

Orally disintegrating selegiline for the treatment of Parkinson's disease

Authors: Löhle, Matthias; Storch, Alexander

Source: Expert Opinion on Pharmacotherapy, Volume 9, Number 16, November 2008 , pp. 2881-2891(11)

Publisher: Informa Healthcare

Synthesis of Chiral 3-Methyl- and 3-Methyl-N-propargyl-1,2,3,4- tetrahydroisoquinoline and Prevention of MPP+-Induced Cytotoxicity

Authors: Saitoh, Toshiaki; Yamashita, Aki; Abe, Kenji; Ogawa, Keita; Kitabatake, Michikazu; Taguchi, Kyoji; Horiguchi, Yoshie

Source: Medicinal Chemistry, Volume 4, Number 6, November 2008 , pp. 531-538(8)

Publisher: Bentham Science Publishers

Transdermal drug delivery has ideal properties in the elderly

Author: Adis International Limited,

Source: Drugs & Therapy Perspectives, Volume 24, Number 12, December 2008 , pp. 25-26(2)

Publisher: Adis International

CYP2B6: New Insights into a Historically Overlooked Cytochrome P450 Isozyme

Authors: Wang, Hongbing; Tompkins, Leslie M.

Source: Current Drug Metabolism, Volume 9, Number 7, September 2008 , pp. 598-610(13)

Publisher: Bentham Science Publishers

The Effects of Antidepressants in Parkinson's Disease: A Meta-Analysis

Authors: Frisina, Pasquale; Tenenbaum, Harriet; Borod, Joan; Foldi, Nancy

Source: International Journal of Neuroscience, Volume 118, Number 5, May 2008 , pp. 667-682(16)

Publisher: Informa Healthcare

Selegiline reduces cisplatin-induced neuronal death in neuroblastoma cells

Authors: Müller, Thomas; Przuntek, Horst; Rieks, Meike; Mackowiak, Anita

Source: Neurological Research, Volume 30, Number 4, May 2008 , pp. 417-419(3)

Publisher: Maney Publishing

Comparison of neuroprotective and neurorestorative capabilities of rasagiline and selegiline against lactacystin-induced nigrostriatal dopaminergic degeneration

Authors: Zhu, Wen; Xie, Wenjie; Pan, Tianhong; Jankovic, Joseph; Li, Jun; Youdim, Moussa B. H.; Le, Weidong

Source: Journal of Neurochemistry, Volume 105, Number 5, June 2008 , pp. 1970-1978(9)

Publisher: Blackwell Publishing

Antiparkinsonians: Obsessive compulsive disorders: 7 case reports

Source: Reactions, Volume 1, Number 1189, 2008-02-16 , pp. 8-8(1)

Publisher: Adis International

Manage levodopa-induced motor complications in patients with Parkinson's disease with careful selection of other antiparkinsonian agents

Author: Adis International Limited,

Source: Drugs & Therapy Perspectives, Volume 24, Number 1, January 2008 , pp. 17-21(5)

Publisher: Adis International

PSYCHOPHARMACOLOGY COLUMN WHY CHOOSE SELEGILINE TRANSDERMAL SYSTEM FOR REFRACTORY DEPRESSION?

Author: Tobin, Mary

Source: Issues in Mental Health Nursing, Volume 28, Number 2, March 2007 , pp. 223-228(6)

Publisher: Informa Healthcare

Selegiline transdermal system in the treatment of depressive disorders

Authors: Baghai, Thomas C; Eser, Daniela; Schule, Cornelius; Born, Christoph; Rupprecht, Rainer

Source: Future Neurology, Volume 2, Number 6, November 2007 , pp. 601-611(11)

Publisher: Future Medicine

Zydis selegiline in the management of Parkinson's disease

Authors: Poston, Kathleen L; Waters, Cheryl

Source: Expert Opinion on Pharmacotherapy, Volume 8, Number 15, October 2007 , pp. 2615-2624(10)

Publisher: Informa Healthcare

Community and Long-Term Care Management of Parkinson's Disease in the Elderly: Focus on Monoamine Oxidase Type B Inhibitors

Authors: Chen, Jack J.; Fernandez, Hubert H.

Source: Drugs & Aging, Volume 24, Number 8, 2007 , pp. 663-680(18)

Publisher: Adis International

Medical Management of Levodopa-Associated Motor Complications in Patients with Parkinson's Disease

Authors: Jankovic, Joseph; Stacy, Mark

Source: CNS Drugs, Volume 21, Number 8, 2007 , pp. 677-692(16)

Publisher: Adis International

Antioxidant Effects of SelegilIne in Oxidative Stress Induced by Iron Neonatal Treatment in Rats

Authors: Budni, Patrícia; Lima, Maria; Polydoro, Manuela; Moreira, José; Schroder, Nadja; Dal-Pizzol, Felipe

Source: Neurochemical Research, Volume 32, Number 6, June 2007 , pp. 965-972(8)

Publisher: Springer